91 related articles for article (PubMed ID: 7532164)
1. The effect of high-dose methylprednisolone combined chemotherapy on CD34-positive cells in acute lymphoblastic leukemia.
Tuncer AM; Hiçsönmez G; Gümrük F; Albayrak D; Duru F; Güzel E; Sayli T
Hematol Pathol; 1994; 8(4):169-75. PubMed ID: 7532164
[TBL] [Abstract][Full Text] [Related]
2. The effect of short-course high-dose corticosteroid therapy on peripheral blood CD34+ progenitor cells in children with acute leukemia.
Cetin M; Hiçsönmez G; Tuncer AM; Kansu E; Canpynar H
Exp Hematol; 1996 Aug; 24(10):1191-4. PubMed ID: 8765493
[TBL] [Abstract][Full Text] [Related]
3. The effect of high-dose methylprednisolone on CD34-positive bone marrow cells in the children with acute myeloblastic leukemia.
Tuncer AM; Hiçsönmez G; Gümrük F; Albayrak D; Duru F; Güzel E; Sayli T
Turk J Pediatr; 1995; 37(4):345-9. PubMed ID: 8560602
[TBL] [Abstract][Full Text] [Related]
4. The effect of short-course high-dose methylprednisolone on peripheral blood CD34+ progenitor cells of children with acute leukemia during remission induction therapy.
Tunç B; Oner AF; Hiçsönmez G
Turk J Pediatr; 2002; 44(1):1-4. PubMed ID: 11858371
[TBL] [Abstract][Full Text] [Related]
5. Comparision of the apoptotic effects on lymphoblasts and on increase of myeloid lineage cells of a short-time, high-dose methylprednisolone and the conventional-dose prednisolone treatments in children with acute lymphoblastic leukemia.
Erduran E; Tekelioglu Y; Karakas T; Gedik Y; Mert FM
Pediatr Hematol Oncol; 2006; 23(7):587-98. PubMed ID: 16928654
[TBL] [Abstract][Full Text] [Related]
6. Myeloprotective effect of short-course high-dose methylprednisolone treatment before consolidation therapy in children with acute myeloblastic leukemia.
Elmas SA; Cetin M; Tuncer M; Hiçsönmez G
Am J Hematol; 2005 Sep; 80(1):1-5. PubMed ID: 16138333
[TBL] [Abstract][Full Text] [Related]
7. Proliferation of myeloid lineage cells and apoptosis of lymphoblastic leukemic cells induced by short-course high-dose methylprednisolone in patients with acute lymphoblastic leukemia.
Yildiran A; Erduran E; Tekelioğlu Y; Dilber E; Gedik Y
Turk J Pediatr; 2002; 44(2):116-21. PubMed ID: 12026198
[TBL] [Abstract][Full Text] [Related]
8. Effect of short-course, high-dose steroid therapy in a child with myelodysplastic syndrome.
Hiçsönmez G; Tunç B; Olcay L; Tuncer MA
Pediatr Hematol Oncol; 2001 Dec; 18(8):525-9. PubMed ID: 11764102
[TBL] [Abstract][Full Text] [Related]
9. Bone mineral density and serum bone turnover markers in survivors of childhood acute lymphoblastic leukemia: comparison of megadose methylprednisolone and conventional-dose prednisolone treatments.
Alikasifoglu A; Yetgin S; Cetin M; Tuncer M; Gumruk F; Gurgey A; Yordam N
Am J Hematol; 2005 Oct; 80(2):113-8. PubMed ID: 16184587
[TBL] [Abstract][Full Text] [Related]
10. Benefit of high-dose methylprednisolone in comparison with conventional-dose prednisolone during remission induction therapy in childhood acute lymphoblastic leukemia for long-term follow-up.
Yetgin S; Tuncer MA; Cetin M; Gümrük F; Yenicesu I; Tunç B; Oner AF; Toksoy H; Koç A; Aslan D; Ozyürek E; Olcay L; Atahan L; Tunçbilek E; Gürgey A
Leukemia; 2003 Feb; 17(2):328-33. PubMed ID: 12592331
[TBL] [Abstract][Full Text] [Related]
11. The effect of short course high dose methylprednisolon therapy on fibrinogen level in children with acute lymphoblastic leukemia. A preliminary study.
Toksöz H; Unal S; Kirazli S; Gürgey A
Leuk Res; 2004 May; 28(5):533-5. PubMed ID: 15068907
[TBL] [Abstract][Full Text] [Related]
12. The dose related effect of steroids on blast reduction rate and event free survival in children with acute lymphoblastic leukemia.
Yetgin S; Cetin M
Leuk Lymphoma; 2003 Mar; 44(3):489-95. PubMed ID: 12688320
[TBL] [Abstract][Full Text] [Related]
13. High-dose methylprednisolone, low-dose cytosine arabinoside, and mitoxantrone in children with myelodysplastic syndromes.
Hiçsönmez G; Tuncer AM; Sayli T; Güler E; Cetin M; Ozbek N; Mufti GJ
Hematol Pathol; 1995; 9(3-4):185-93. PubMed ID: 8655463
[TBL] [Abstract][Full Text] [Related]
14. The role of short course of high-dose methylprednisolone in children with acute myeloblastic leukemia (FAB M2) presented with myeloid tumor.
Hiçsönmez G; Cetin M; Aslan D; Ozyürek E
Pediatr Hematol Oncol; 2003; 20(5):373-9. PubMed ID: 12775535
[TBL] [Abstract][Full Text] [Related]
15. Expression of CD10, CD19 and CD34 markers in bone marrow samples of children with precursor B-cell acute lymphoblastic leukemia in clinical and hematological remission.
Cáp J; Babusíková O; Kaiserová E; Jamárik M
Neoplasma; 1998; 45(4):231-6. PubMed ID: 9890666
[TBL] [Abstract][Full Text] [Related]
16. Comparison of idarubicin to daunomycin in a randomized multidrug treatment of childhood acute lymphoblastic leukemia at first bone marrow relapse: a report from the Children's Cancer Group.
Feig SA; Ames MM; Sather HN; Steinherz L; Reid JM; Trigg M; Pendergrass TW; Warkentin P; Gerber M; Leonard M; Bleyer WA; Harris RE
Med Pediatr Oncol; 1996 Dec; 27(6):505-14. PubMed ID: 8888809
[TBL] [Abstract][Full Text] [Related]
17. Fractionated cyclophosphamide added to the IVAP regimen (idarubicin-vincristine-L-asparaginase-prednisone) could lower the risk of primary refractory disease in T-lineage but not B-lineage acute lymphoblastic leukemia: first results from a phase II clinical study.
Bassan R; Pogliani E; Lerede T; Fabris P; Rossi G; Morandi S; Casula P; Lambertenghi-Deliliers G; Vespignani M; Izzi T; Coser P; Corneo G; Barbui T
Haematologica; 1999 Dec; 84(12):1088-93. PubMed ID: 10586210
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the effect of high-dose methylprednisolone with conventional-dose prednisolone in acute lymphoblastic leukemia patients with randomization.
Yetgin S; Gürgey A; Tuncer AM; Cetin M; Ozbek N; Sayli T; Güler E; Kara A; Olcay L; Duru F; Gümrük F; Atahan L; Tunçbilek E
Leuk Res; 1998 Jun; 22(6):485-93. PubMed ID: 9678714
[TBL] [Abstract][Full Text] [Related]
19. Residual bone marrow leukemic progenitor cell burden after induction chemotherapy in pediatric patients with acute lymphoblastic leukemia.
Uckun FM; Stork L; Seibel N; Sarquis M; Bedros C; Sather H; Sensel M; Reaman GH; Gaynon PS
Clin Cancer Res; 2000 Aug; 6(8):3123-30. PubMed ID: 10955793
[TBL] [Abstract][Full Text] [Related]
20. Role of allogenic bone marrow transplantation in adolescent or adult patients with acute lymphoblastic leukaemia or lymphoblastic lymphoma in first remission.
De Witte T; Awwad B; Boezeman J; Schattenberg A; Muus P; Raemaekers J; Preijers F; Strijckmans P; Haanen C
Bone Marrow Transplant; 1994 Nov; 14(5):767-74. PubMed ID: 7889010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
